2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 1.087.866 | 695.135 | 611.195 | 420.369 | 586.955 | 57.320 | 49.869 | 60.715 | 61.033 | 68.683 |
Total Income - EUR | 1.237.480 | 699.820 | 699.629 | 420.373 | 586.968 | 466.040 | 50.043 | 60.715 | 63.739 | 134.980 |
Total Expenses - EUR | 1.165.859 | 650.417 | 594.786 | 395.241 | 346.485 | 69.260 | 17.394 | 17.969 | 29.244 | 45.737 |
Gross Profit/Loss - EUR | 71.620 | 49.403 | 104.844 | 25.132 | 240.483 | 396.780 | 32.648 | 42.747 | 34.495 | 89.242 |
Net Profit/Loss - EUR | 60.091 | 40.234 | 88.062 | 20.173 | 234.614 | 391.862 | 31.829 | 40.962 | 33.080 | 87.893 |
Employees | 17 | 10 | 7 | 6 | 4 | 1 | 1 | 0 | 0 | 1 |
Check the financial reports for the company - Medicorclinics Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 561.074 | 421.555 | 189.516 | 57.364 | 23.787 | 11.060 | 9.583 | 8.202 | 7.653 | 0 |
Current Assets | 182.720 | 157.822 | 70.227 | 140.547 | 490.125 | 500.678 | 124.153 | 137.354 | 91.958 | 98.188 |
Inventories | 15.257 | 40.267 | 25.775 | 27.814 | 24.684 | 0 | 0 | 0 | 0 | 0 |
Receivables | 109.714 | 27.717 | 28.783 | 65.870 | 289.880 | 361.050 | 116.140 | 131.274 | 70.878 | 97.931 |
Cash | 57.749 | 89.837 | 15.668 | 46.863 | 175.561 | 139.628 | 8.013 | 6.079 | 21.080 | 256 |
Shareholders Funds | 483.625 | 527.895 | 200.377 | 126.563 | 339.062 | 494.277 | 132.303 | 139.207 | 98.070 | 87.944 |
Social Capital | 36.947 | 37.255 | 36.875 | 36.251 | 35.586 | 34.897 | 34.235 | 33.476 | 20 | 20 |
Debts | 259.560 | 51.482 | 59.366 | 71.348 | 174.851 | 17.461 | 1.433 | 6.349 | 1.541 | 10.244 |
Income in Advance | 748 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8610 - 8610" | |||||||||
CAEN Financial Year |
8610
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Medicorclinics Srl